Safety and effect of a low-and high-dose multi-strain probiotic supplement on microbiota in a general adult population: A randomized, double-blind, placebo-controlled study
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Few studies have focused on dose-response analyses of multi-strain probiotics in the general adult population. This study aimed at comparing how a low- and high-dose of a multi-strain probiotic supplement (containing Lactobacillus helveticus R0052, Lactobacillus rhamnosus R0011, Lactobacillus casei R0215, Pediococcus acidilactici R1001, Bifidobacterium breve R0070, Bifidobacterium longum ssp. longum BB536, Lactobacillus plantarum R1012, Lactococcus lactis ssp. lactis R1058) affected microbiota composition, transit persistence and safety in adults. After a 7-d baseline, participants were randomized to receive capsules containing 5 or 25 billion CFU, or placebo daily for 28 days, followed by a 7-d washout. Digestive health and general wellness were assessed. Fecal microbiota composition was analyzed using 16S rRNA gene amplicon sequencing and strain persistence, by qPCR. Participants’ gastrointestinal and general wellbeing were unaffected. No adverse events were associated with either dose. Supplemented strains contributed to the Lactobacillus and Bifidobacterium genera detected in stool, with 0.40 ± 0.11% and 0.51 ± 0.26%, respectively, in the high-dose group. Strain-specific qPCR assays revealed variable levels of post-intervention persistence between strains. Sequencing and composition analyses using the 16S V4 region revealed a decrease in Holdemania and increase in Bacteroidales. The formulation was well tolerated in this sample of the general adult population, even at the higher dose. The strains appear to have influenced microbiota composition minimally, as expected in the absence of dysbiosis, and consistently with the dose administered. Overall, the results provide a rationale to study the effects this formulation on microbiota composition in individuals exhibiting dysbiosis associated with metabolic disorders or obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomized studies involving up to 25 billion colony-forming units in healthy subjects did not show an increase in adverse events or laboratory abnormalities [72].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [72]
Citations
Cites
Scikit-learn: Machine Learning in Python
Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Müller, A., Nothman, J., Louppe, G., et al. (2012) · arXiv · doi:10.48550/arxiv.1201.0490 · Cited by 71,016
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
Bolyen, E., Rideout, J. R., Dillon, M. R., Bokulich, N. A., Abnet, C. C., Al-Ghalith, G. A., Alexander, H., Alm, E. J., Arumugam, M., Asnicar, F., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0209-9 · Cited by 23,742
International physical activity questionnaire: 12-country reliability and validity
CRAIG, C. L., MARSHALL, A. L., SJ??STR??M, M., BAUMAN, A. E., BOOTH, M. L., AINSWORTH, B. E., PRATT, M., EKELUND, U., YNGVE, A., SALLIS, J. F., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000078924.61453.fb · Cited by 21,619
Use of Ranks in One-Criterion Variance Analysis
Kruskal, W. H., & Wallis, W. A. (1952) · Journal of the American Statistical Association · doi:10.1080/01621459.1952.10483441 · Cited by 13,912 · cited 1×
“Upon examination of the table’s per sample sequence counts, the sampling depth of 3 203 was chosen for the core-metrics diversity analyses (Kruskal and Wallis 1952; McDonald et al. 2012; Bokulich et al. 2013).”
MethodGreengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing
Bokulich, N. A., Subramanian, S., Faith, J. J., Gevers, D., Gordon, J. I., Knight, R., Mills, D. A., & Caporaso, J. G. (2013) · Nature Methods · doi:10.1038/nmeth.2276 · Cited by 4,401
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · cited 1×
“Bacteroidales order (namely the Bacteroides) have been identified as potential drivers of leanness in another study (Ridaura et al. 2013).”
Stool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244 · cited 1×
“The Bristol Stool Form scale was used as a proxy to classify the participants’ transit time into three categories: slow, normal, or fast (Lewis and Heaton 1997).”
MethodPopulation-level analysis of gut microbiome variation
Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M. J., Valles-Colomer, M., Vandeputte, D., et al. (2016) · Science · doi:10.1126/science.aad3503 · Cited by 2,400 · cited 1×
“Indeed, the high level of variability in the composition of a ‘healthy’ or ‘normal’ microbiota is now well recognized (Gevers et al. 2012; Falony et al. 2016; Lavelle and Hill 2019).”
BackgroundDhariwal, A., Chong, J., Habib, S., King, I. L., Agellon, L. B., & Xia, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx295 · Cited by 1,885
Deblur Rapidly Resolves Single-Nucleotide Community Sequence Patterns
Amir, A., McDonald, D., Navas-Molina, J. A., Kopylova, E., Morton, J. T., Zech Xu, Z., Kightley, E. P., Thompson, L. R., Hyde, E. R., Gonzalez, A., et al. (2017) · mSystems · doi:10.1128/msystems.00191-16 · Cited by 1,881
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
Gopalakrishnan, V., Helmink, B. A., Spencer, C. N., Reuben, A., & Wargo, J. A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.015 · Cited by 1,392 · cited 1×
“In addition, an increasing level of attention is being directed toward the role of probiotics in other dysbiosis-associated diseases and disorders such as obesity, cardiovascular disease, diabetes, and cancer (Hampe and Roth 2017; Gopalakrishnan et al. 2018; Mazloom et al. 2019; Tang et al. 2019).”
BackgroundThe resilience of the intestinal microbiota influences health and disease
Sommer, F., Anderson, J. M., Bharti, R., Raes, J., & Rosenstiel, P. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.58 · Cited by 1,058
McDonald, D., Clemente, J. C., Kuczynski, J., Rideout, J. R., Stombaugh, J., Wendel, D., Wilke, A., Huse, S., Hufnagle, J., Meyer, F., et al. (2012) · GigaScience · doi:10.1186/2047-217x-1-7 · Cited by 897
Revicki, D. A., Wood, M., Wiklund, I., & Crawley, J. (1997) · Quality of Life Research · doi:10.1023/a:1008841022998 · Cited by 617
Kristensen, N. B., Bryrup, T., Allin, K. H., Nielsen, T., Hansen, T. H., & Pedersen, O. (2016) · Genome Medicine · doi:10.1186/s13073-016-0300-5 · Cited by 561 · cited 2×
“Consequently, studies assessing the effects of a variety of probiotic formulations on microbiota composition in populations described as healthy have produced mixed results so far (Kristensen et al. 2016).”
BackgroundIntestinal Microbiota in Cardiovascular Health and Disease
Tang, W. H. W., Bäckhed, F., Landmesser, U., & Hazen, S. L. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.024 · Cited by 502
The Human Microbiome Project: A Community Resource for the Healthy Human Microbiome
Gevers, D., Knight, R., Petrosino, J. F., Huang, K., McGuire, A. L., Birren, B. W., Nelson, K. E., White, O., Methé, B. A., & Huttenhower, C. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001377 · Cited by 493
The effects of probiotics on depressive symptoms in humans: a systematic review
Wallace, C. J. K., & Milev, R. (2017) · Annals of General Psychiatry · doi:10.1186/s12991-017-0138-2 · Cited by 471 · cited 1×
“In humans, compelling evidence is accumulating to support a beneficial effect of probiotics on gastrointestinal dysfunction and depressive-like symptoms (Wallace and Milev 2017; Parker et al. 2018; Nadeem et al. 2019).”
BackgroundLow diversity gut microbiota dysbiosis: drivers, functional implications and recovery
Kriss, M., Hazleton, K. Z., Nusbacher, N. M., Martin, C. G., & Lozupone, C. A. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.07.003 · Cited by 416
de Boer, M. R., Waterlander, W. E., Kuijper, L. D., Steenhuis, I. H., & Twisk, J. W. (2015) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-015-0162-z · Cited by 370
Lippert, K., Kedenko, L., Antonielli, L., Kedenko, I., Gemeier, C., Leitner, M., Kautzky-Willer, A., Paulweber, B., & Hackl, E. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0184 · Cited by 323
Close social relationships correlate with human gut microbiota composition
Dill-McFarland, K. A., Tang, Z.-Z., Kemis, J. H., Kerby, R. L., Chen, G., Palloni, A., Sorenson, T., Rey, F. E., & Herd, P. (2019) · Scientific Reports · doi:10.1038/s41598-018-37298-9 · Cited by 233
The human gut microbiome in health: Establishment and resilience of microbiota over a lifetime
Greenhalgh, K., Meyer, K. M., Aagaard, K. M., & Wilmes, P. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.13318 · Cited by 218 · cited 1×
“However, its corollary remains undefined in terms of composition; the core microbial signature of a ‘normal’ or ‘healthy’ microbiota appears to vary significantly among individuals according to genetics, age, geography or lifestyle-related factors (Greenhalgh et al. 2016).”
BackgroundProbiotics: How Effective Are They in the Fight against Obesity?
Mazloom, K., Siddiqi, I., & Covasa, M. (2019) · Nutrients · doi:10.3390/nu11020258 · Cited by 192
Probiotics and gastrointestinal conditions: An overview of evidence from the Cochrane Collaboration
Parker, E. A., Roy, T., D'Adamo, C. R., & Wieland, L. S. (2018) · Nutrition · doi:10.1016/j.nut.2017.06.024 · Cited by 147
Toscano, M., De Grandi, R., Stronati, L., De Vecchi, E., & Drago, L. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i15.2696 · Cited by 127
Ahlroos, T., & Tynkkynen, S. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2008.04018.x · Cited by 107
MacPherson, C. W., Mathieu, O., Tremblay, J., Champagne, J., Nantel, A., Girard, S.-A., & Tompkins, T. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-29229-5 · Cited by 104
Self-citationTuohy, K. M., Pinart-Gilberga, M., Jones, M., Hoyles, L., McCartney, A. L., & Gibson, G. R. (2006) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2006.03154.x · Cited by 99
Ning, H., Horn, L. V., Shay, C. M., & Lloyd‐Jones, D. M. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.09.020 · Cited by 75
Ford, A. L., Nagulesapillai, V., Piano, A., Auger, J., Girard, S.-A., Christman, M., Tompkins, T. A., & Dahl, W. J. (2020) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2019.12.009 · Cited by 63 · cited 1×
“…of microbial species and strains Genus-specific PCR assays were performed using the CFX384TM Touch Real-Time PCR Detection System (Bio-Rad, USA) and plate preparation was automated using the epMotion 5075 tc liquid handling robot (Eppendorf, Germany), as previously described (Ford et al. 2020).”
MethodSelf-citationNadeem, I., Rahman, M. Z., Ad‐Dab'bagh, Y., & Akhtar, M. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12804 · Cited by 61
Probiotic strains and mechanistic insights for the treatment of type 2 diabetes
Hampe, C. S., & Roth, C. L. (2017) · Endocrine · doi:10.1007/s12020-017-1433-z · Cited by 49
Arioli, S., Koirala, R., Taverniti, V., Fiore, W., & Guglielmetti, S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01720 · Cited by 41
Gut Microbiome in Health and Disease
Lavelle, A., & Hill, C. (2019) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.02.003 · Cited by 40
Radicioni, M. M., Koirala, R., Fiore, W., Leuratti, C., Guglielmetti, S., & Arioli, S. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1860-5 · Cited by 31
Taverniti, V., Koirala, R., Via, A. D., Gargari, G., Leonardis, E., Arioli, S., & Guglielmetti, S. (2019) · Nutrients · doi:10.3390/nu11020285 · Cited by 28
Erratum to: The effects of probiotics on depressive symptoms in humans: a systematic review
Wallace, C. J. K., & Milev, R. V. (2017) · Annals of General Psychiatry · doi:10.1186/s12991-017-0141-7 · Cited by 24
Probiotics and Disease: A Comprehensive Summary-Part 1, Mental and Neurological Health.
Dolan, K. E., Finley, H. J., Burns, C. M., Gasta, M. G., Gossard, C. M., Parker, E., Pizano, J. M., Williamson, C. B., & Lipski, E. A. (2016) · PubMed Central · Cited by 18
Williamson, C. B., Burns, C. M., Gossard, C. M., Pizano, J. M., Dolan, K. E., Finley, H. J., Gasta, M. G., Parker, E., & Lipski, E. A. (2017) · PubMed Central · Cited by 13
Alyousif, Z., Miller, J. L., Sandoval, M., MacPherson, C. W., Nagulesapillai, V., & Dahl, W. J. (2018) · Trials · doi:10.1186/s13063-018-2648-x · Cited by 12
Self-citationFinley, H. J., Gasta, M. G., Dolan, K. E., Pizano, J. M., Gossard, C. M., Williamson, C. B., Burns, C. M., Parker, E., & Lipski, E. A. (2018) · Europe PMC (PubMed Central) · Cited by 6
Probiotics and Disease: A Comprehensive Summary-Part 7, Immune Disorders.
Pizano, J. M., Williamson, C. B., Dolan, K. E., Gossard, C. M., Burns, C. M., Gasta, M. G., Finley, H. J., Parker, E., & Lipski, E. A. (2017) · Europe PMC (PubMed Central) · Cited by 4
Nagulesapillai, V., Belvis, J., Tompkins, T. A., & Girard, S. (2017) · The FASEB Journal · doi:10.1096/fasebj.31.1_supplement.lb207 · Cited by 3
Self-citationColonization and persistence capacity of a multi-strain probiotic in food allergy.
Mennini, M., Reddel, S., Arasi, S., CHIERICO, F. D., Napolitano, T., Riccardi, C., Fierro, V., Vernocchi, P., Putignani, L., & Fiocchi, A. G. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.12.699 · Cited by 2
Research works printed but not linked: 5
- Dolan KE, 2016, Integr Med, 15, 46
- Finley HJ, 2018, Integr Med, 17, 38
- Pedregosa F, 2011, J Mach Learn Res, 12, 2825
- Pizano JM, 2017, Integr Med, 16, 46
- Williamson CB, 2017, Integr Med, 16, 30
Cited by
Zhao, Z., Xiao, G., Xia, J., Guo, H., Yang, X., Jiang, Q., Wang, H., Hu, J., & Zhang, C. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.09.018 · Cited by 41
Composition, Properties, and Beneficial Effects of Functional Beverages on Human Health
Panou, A., & Karabagias, I. K. (2025) · Beverages · doi:10.3390/beverages11020040 · Cited by 37
Routier, A., Blaizot, A., Agossa, K., & Dubar, M. (2021) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2021.105196 · Cited by 34
Current Concepts in Probiotic Safety and Efficacy
Churin, A. A., Sokolyanskaya, L. O., Lukina, A. P., & Karnachuk, O. V. (2026) · Nutrients · doi:10.3390/nu18040696 · Cited by 31
“Randomized studies involving up to 25 billion colony-forming units in healthy subjects did not show an increase in adverse events or laboratory abnormalities [72].”
Duysburgh, C., den Abbeele, P. V., Morera, M., & Marzorati, M. (2021) · Beneficial Microbes · doi:10.3920/bm2020.0180 · Cited by 30
Metadata
- Authors
- Tremblay, A., Fatani, A., Ford, A. L., Piano, A., Nagulesapillai, V., Auger, J., MacPherson, C. W., Christman, M. C., Tompkins, T. A., & Dahl, W. J.
- Affiliations
- Rosell Institute for Microbiome and Probiotics, Montreal, Quebec, Canada
- University of Florida (US)
- MCC Statistical Consulting LLC, Gainesville, FL, USA
- Corresponding author
- Dahl, Wendy J.
- Venue
- Journal of Dietary Supplements
- Publisher
- Informa UK Limited
- Published
- 2020-04-20
- Volume
- 18
- Issue
- 3
- Pages
- 227-247
- ISSN
- 1939-0211 (ISSN-L)
- 1939-022X
- OpenAlex
- W3016997364
- Cited by
- 31
- References
- 46
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 5 · 2023: 7 · 2022: 3 · 2021: 2 · 2020: 1
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Dietary Supplements (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Keywords
- gut microbiota composition, Lactobacillus, Bifidobacterium, fecal microbiota, Bacteroidales, probiotic safety, general adult population, gut health
- MeSH terms
- Adult, Bifidobacterium, Double-Blind Method, Feces, Humans, Lactobacillus, RNA, Ribosomal, 16S, Probiotics, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.